{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T09:16:33Z","timestamp":1788340593751,"version":"build-2803163510"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,5,10]],"date-time":"2018-05-10T00:00:00Z","timestamp":1525910400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003042","name":"Else Kr\u00f6ner-Fresenius-Stiftung","doi-asserted-by":"publisher","award":["2012_A303"],"award-info":[{"award-number":["2012_A303"]}],"id":[{"id":"10.13039\/501100003042","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["TRR 179"],"award-info":[{"award-number":["TRR 179"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Nucleic Acids"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.omtn.2018.05.006","type":"journal-article","created":{"date-parts":[[2018,6,7]],"date-time":"2018-06-07T19:02:46Z","timestamp":1528398166000},"page":"242-253","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":67,"special_numbering":"C","title":["One-Vector System for Multiplexed CRISPR\/Cas9 against Hepatitis B Virus cccDNA Utilizing High-Capacity Adenoviral Vectors"],"prefix":"10.1016","volume":"12","author":[{"given":"Maren","family":"Schiwon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Ehrke-Schulz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Oswald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorsten","family":"Bergmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Michler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Protzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Ehrhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2018.05.006_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1099\/vir.0.003087-0","article-title":"Adenoviruses: update on structure and function","volume":"90","author":"Russell","year":"2009","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.omtn.2018.05.006_bib2","doi-asserted-by":"crossref","first-page":"a013003","DOI":"10.1101\/cshperspect.a013003","article-title":"Adenovirus DNA replication","volume":"5","author":"Hoeben","year":"2013","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.omtn.2018.05.006_bib3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1089\/hum.2013.2527","article-title":"Adenovirus: the first effective in\u00a0vivo gene delivery vector","volume":"25","author":"Crystal","year":"2014","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtn.2018.05.006_bib4","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/rmv.494","article-title":"Adenovirus: from foe to friend","volume":"16","author":"Gon\u00e7alves","year":"2006","journal-title":"Rev. Med. Virol."},{"issue":"Suppl 1","key":"10.1016\/j.omtn.2018.05.006_bib5","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1038\/sj.gt.3302612","article-title":"Gutless adenovirus: last-generation adenovirus for gene therapy","volume":"12","author":"Alba","year":"2005","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtn.2018.05.006_bib6","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/mt.2015.194","article-title":"Development of Novel Adenoviral Vectors to Overcome Challenges Observed With HAdV-5-based Constructs","volume":"24","author":"Alonso-Padilla","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2018.05.006_bib7","doi-asserted-by":"crossref","first-page":"14057","DOI":"10.1038\/mtm.2014.57","article-title":"Efficient genome editing in hematopoietic stem cells with helper-dependent Ad5\/35 vectors expressing site-specific endonucleases under microRNA regulation","volume":"1","author":"Saydaminova","year":"2015","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtn.2018.05.006_bib8","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1529-8019.2012.01457.x","article-title":"Biopump: Autologous skin-derived micro-organ genetically engineered to provide sustained continuous secretion of therapeutic proteins","volume":"24","author":"Mitrani","year":"2011","journal-title":"Dermatol. Ther. (Heidelb.)"},{"key":"10.1016\/j.omtn.2018.05.006_bib9","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/nprot.2009.4","article-title":"A rapid protocol for construction and production of high-capacity adenoviral vectors","volume":"4","author":"Jager","year":"2009","journal-title":"Nat. Protoc."},{"issue":"5 Pt B","key":"10.1016\/j.omtn.2018.05.006_bib10","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.jmb.2015.10.014","article-title":"Origins of Programmable Nucleases for Genome Engineering","volume":"428","author":"Chandrasegaran","year":"2016","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.omtn.2018.05.006_bib11","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/gt.2013.83","article-title":"Multiple copies of a linear donor fragment released in\u00a0situ from a vector improve the efficiency of zinc-finger nuclease-mediated genome editing","volume":"21","author":"Zhang","year":"2014","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtn.2018.05.006_bib12","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1089\/hum.2012.172","article-title":"Efficient clinical scale gene modification via zinc finger nuclease-targeted disruption of the HIV co-receptor CCR5","volume":"24","author":"Maier","year":"2013","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtn.2018.05.006_bib13","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/mt.2011.310","article-title":"Zinc-finger nuclease editing of human cxcr4 promotes HIV-1 CD4(+) T\u00a0cell resistance and enrichment","volume":"20","author":"Yuan","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2018.05.006_bib14","doi-asserted-by":"crossref","first-page":"e63","DOI":"10.1093\/nar\/gks1446","article-title":"Differential integrity of TALE nuclease genes following adenoviral and lentiviral vector gene transfer into human cells","volume":"41","author":"Holkers","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2018.05.006_bib15","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ymeth.2014.02.017","article-title":"Construction and characterization of adenoviral vectors for the delivery of TALENs into human cells","volume":"69","author":"Holkers","year":"2014","journal-title":"Methods"},{"key":"10.1016\/j.omtn.2018.05.006_bib16","doi-asserted-by":"crossref","first-page":"e80281","DOI":"10.1371\/journal.pone.0080281","article-title":"Rapid assembly of customized TALENs into multiple delivery systems","volume":"8","author":"Zhang","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.omtn.2018.05.006_bib17","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.stem.2014.06.016","article-title":"Targeted gene correction minimally impacts whole-genome mutational load in human-disease-specific induced pluripotent stem cell clones","volume":"15","author":"Suzuki","year":"2014","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.omtn.2018.05.006_bib18","doi-asserted-by":"crossref","first-page":"5105","DOI":"10.1038\/srep05105","article-title":"Adenoviral vector delivery of RNA-guided CRISPR\/Cas9 nuclease complexes induces targeted mutagenesis in a diverse array of human cells","volume":"4","author":"Maggio","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtn.2018.05.006_bib19","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1099\/vir.0.000139","article-title":"Inhibition of HIV-1 infection of primary CD4+ T-cells by gene editing of CCR5 using adenovirus-delivered CRISPR\/Cas9","volume":"96","author":"Li","year":"2015","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.omtn.2018.05.006_bib20","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.1016\/j.febslet.2014.09.008","article-title":"Efficient gene editing in adult mouse livers via adenoviral delivery of CRISPR\/Cas9","volume":"588","author":"Cheng","year":"2014","journal-title":"FEBS Lett."},{"key":"10.1016\/j.omtn.2018.05.006_bib21","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1161\/CIRCRESAHA.115.304351","article-title":"Permanent alteration of PCSK9 with in\u00a0vivo CRISPR-Cas9 genome editing","volume":"115","author":"Ding","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.omtn.2018.05.006_bib22","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/mt.2015.192","article-title":"CRISPR-mediated Genome Editing Restores Dystrophin Expression and Function in mdx Mice","volume":"24","author":"Xu","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2018.05.006_bib23","doi-asserted-by":"crossref","first-page":"7401","DOI":"10.1038\/s41598-017-07642-6","article-title":"ssAAVs containing cassettes encoding SaCas9 and guides targeting hepatitis B virus inactivate replication of the virus in cultured cells","volume":"7","author":"Scott","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtn.2018.05.006_bib24","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1128\/MMBR.64.1.51-68.2000","article-title":"Hepatitis B virus biology","volume":"64","author":"Seeger","year":"2000","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"10.1016\/j.omtn.2018.05.006_bib25","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1056\/NEJMra0801644","article-title":"Hepatitis B virus infection","volume":"359","author":"Dienstag","year":"2008","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtn.2018.05.006_bib26","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.virol.2014.12.001","article-title":"Suppression of hepatitis B virus DNA accumulation in chronically infected cells using a bacterial CRISPR\/Cas RNA-guided DNA endonuclease","volume":"476","author":"Kennedy","year":"2015","journal-title":"Virology"},{"key":"10.1016\/j.omtn.2018.05.006_bib27","doi-asserted-by":"crossref","first-page":"e186","DOI":"10.1038\/mtna.2014.38","article-title":"The CRISPR\/Cas9 System Facilitates Clearance of the Intrahepatic HBV Templates In\u00a0Vivo","volume":"3","author":"Lin","year":"2014","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2018.05.006_bib28","series-title":"Frontiers in Viral Hepatitis","first-page":"197","article-title":"A transgenic mouse lineage useful for testing antivirals targeting hepatitis B virus","author":"Marion","year":"2003"},{"key":"10.1016\/j.omtn.2018.05.006_bib29","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1073\/pnas.84.4.1005","article-title":"Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA","volume":"84","author":"Sells","year":"1987","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2018.05.006_bib30","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nbt824","article-title":"Inhibition of hepatitis B virus in mice by RNA interference","volume":"21","author":"McCaffrey","year":"2003","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2018.05.006_bib31","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1093\/nar\/gkr218","article-title":"Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting","volume":"39","author":"Cermak","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2018.05.006_bib32","doi-asserted-by":"crossref","first-page":"e1002861","DOI":"10.1371\/journal.pgen.1002861","article-title":"Simple methods for generating and detecting locus-specific mutations induced with TALENs in the zebrafish genome","volume":"8","author":"Dahlem","year":"2012","journal-title":"PLoS Genet."},{"key":"10.1016\/j.omtn.2018.05.006_bib33","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1126\/science.1231143","article-title":"Multiplex genome engineering using CRISPR\/Cas systems","volume":"339","author":"Cong","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.omtn.2018.05.006_bib34","doi-asserted-by":"crossref","first-page":"17113","DOI":"10.1038\/s41598-017-17180-w","article-title":"CRISPR\/Cas9 delivery with one single adenoviral vector devoid of all viral genes","volume":"7","author":"Ehrke-Schulz","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtn.2018.05.006_bib35","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/nbt1319","article-title":"An improved zinc-finger nuclease architecture for highly specific genome editing","volume":"25","author":"Miller","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2018.05.006_bib36","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1002\/jgm.1207","article-title":"Exploring gene-deleted adenoviral vectors for delivery of short hairpin RNAs and reduction of hepatitis B virus infection in mice","volume":"10","author":"Rauschhuber","year":"2008","journal-title":"J.\u00a0Gene Med."},{"key":"10.1016\/j.omtn.2018.05.006_bib37","doi-asserted-by":"crossref","first-page":"e168","DOI":"10.1093\/nar\/gku936","article-title":"Easy quantitative assessment of genome editing by sequence trace decomposition","volume":"42","author":"Brinkman","year":"2014","journal-title":"Nucleic Acids Res."},{"issue":"107","key":"10.1016\/j.omtn.2018.05.006_bib38","first-page":"e52894","article-title":"Cloning and Large-Scale Production of High-Capacity Adenoviral Vectors Based on the Human Adenovirus Type 5","author":"Ehrke-Schulz","year":"2016","journal-title":"J.\u00a0Vis. Exp."},{"key":"10.1016\/j.omtn.2018.05.006_bib39","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.ymthe.2003.08.014","article-title":"Improved system for helper-dependent adenoviral vector production","volume":"8","author":"Palmer","year":"2003","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2018.05.006_bib40","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0042-6822(68)90121-9","article-title":"The polypeptides of adenovirus. I. Evidence for multiple protein components in the virion and a comparison of types 2, 7A, and 12","volume":"36","author":"Maizel","year":"1968","journal-title":"Virology"},{"key":"10.1016\/j.omtn.2018.05.006_bib41","doi-asserted-by":"crossref","first-page":"40","DOI":"10.12665\/J13.Simek","article-title":"FDA perspectives on the use of the adenovirus reference material","volume":"1","author":"Simek","year":"2002","journal-title":"Bioprocess. J."},{"key":"10.1016\/j.omtn.2018.05.006_bib42","doi-asserted-by":"crossref","first-page":"e00049","DOI":"10.7554\/eLife.00049","article-title":"Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus","volume":"1","author":"Yan","year":"2012","journal-title":"eLife"},{"key":"10.1016\/j.omtn.2018.05.006_bib43","series-title":"Therapeutic Applications of Adenoviruses","first-page":"59","article-title":"Helper-Dependent Adenoviral Vectors for Cell and Gene Therapy","author":"Brunetti-Pierri","year":"2016"},{"key":"10.1016\/j.omtn.2018.05.006_bib44","doi-asserted-by":"crossref","first-page":"e5059","DOI":"10.1371\/journal.pone.0005059","article-title":"Comparison of replication-competent, first generation, and helper-dependent adenoviral vaccines","volume":"4","author":"Weaver","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.omtn.2018.05.006_bib45","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/sj.gt.3302441","article-title":"PEGylated helper-dependent adenoviral vectors: highly efficient vectors with an enhanced safety profile","volume":"12","author":"Croyle","year":"2005","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtn.2018.05.006_bib46","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/gt.2010.18","article-title":"An ex\u00a0vivo loop system models the toxicity and efficacy of PEGylated and unmodified adenovirus serotype 5 in whole human blood","volume":"17","author":"Danielsson","year":"2010","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtn.2018.05.006_bib47","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1182\/blood-2009-03-208835","article-title":"Identification of coagulation factor (F)X binding sites on the adenovirus serotype 5 hexon: effect of mutagenesis on FX interactions and gene transfer","volume":"114","author":"Alba","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.omtn.2018.05.006_bib48","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1182\/blood-2009-12-260026","article-title":"Biodistribution and retargeting of FX-binding ablated adenovirus serotype 5 vectors","volume":"116","author":"Alba","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.omtn.2018.05.006_bib49","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nature04721","article-title":"Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity","volume":"441","author":"Roberts","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2018.05.006_bib50","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1099\/jgv.0.000328","article-title":"Adenovirus hexon modifications influence in\u00a0vitro properties of pseudotyped human adenovirus type 5 vectors","volume":"97","author":"Solanki","year":"2016","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.omtn.2018.05.006_bib51","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1016\/j.celrep.2017.05.008","article-title":"An Engineered Virus Library as a Resource for the Spectrum-wide Exploration of Virus and Vector Diversity","volume":"19","author":"Zhang","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.omtn.2018.05.006_bib52","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1089\/hum.2015.087","article-title":"Adenovirus-Mediated Somatic Genome Editing of Pten by CRISPR\/Cas9 in Mouse Liver in Spite of Cas9-Specific Immune Responses","volume":"26","author":"Wang","year":"2015","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtn.2018.05.006_bib53","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1006\/jsre.1994.1082","article-title":"Liver-directed gene therapy: evaluation of liver specific promoter elements","volume":"56","author":"Hafenrichter","year":"1994","journal-title":"J.\u00a0Surg. Res."},{"key":"10.1016\/j.omtn.2018.05.006_bib54","doi-asserted-by":"crossref","first-page":"3394","DOI":"10.1182\/blood.V84.10.3394.bloodjournal84103394","article-title":"Quantitative evaluation of liver-specific promoters from retroviral vectors after in\u00a0vivo transduction of hepatocytes","volume":"84","author":"Hafenrichter","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.omtn.2018.05.006_bib55","doi-asserted-by":"crossref","first-page":"10833","DOI":"10.1038\/srep10833","article-title":"CRISPR\/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus","volume":"5","author":"Ramanan","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtn.2018.05.006_bib56","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1099\/vir.0.000159","article-title":"Inhibition of hepatitis B virus by the CRISPR\/Cas9 system via targeting the conserved regions of the viral genome","volume":"96","author":"Liu","year":"2015","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.omtn.2018.05.006_bib57","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1128\/jvi.62.8.2836-2844.1988","article-title":"Replicative intermediates of hepatitis B virus in HepG2 cells that produce infectious virions","volume":"62","author":"Sells","year":"1988","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtn.2018.05.006_bib58","doi-asserted-by":"crossref","first-page":"5465","DOI":"10.1128\/JVI.02303-05","article-title":"Lipid-mediated introduction of hepatitis B virus capsids into nonsusceptible cells allows highly efficient replication and facilitates the study of early infection events","volume":"80","author":"Rabe","year":"2006","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtn.2018.05.006_bib59","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1128\/JVI.72.3.2055-2061.1998","article-title":"Adenovirus endocytosis via alpha(v) integrins requires phosphoinositide-3-OH kinase","volume":"72","author":"Li","year":"1998","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtn.2018.05.006_bib60","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.1073\/pnas.0911373107","article-title":"The early autophagic pathway is activated by hepatitis B virus and required for viral DNA replication","volume":"107","author":"Sir","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2018.05.006_bib61","doi-asserted-by":"crossref","first-page":"8270","DOI":"10.1128\/JVI.00048-07","article-title":"Phylogenetic analysis and structural predictions of human adenovirus penton proteins as a basis for tissue-specific adenovirus vector design","volume":"81","author":"Madisch","year":"2007","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtn.2018.05.006_bib62","doi-asserted-by":"crossref","first-page":"3923","DOI":"10.1182\/blood.V99.11.3923","article-title":"A new adenoviral helper-dependent vector results in long-term therapeutic levels of human coagulation factor IX at low doses in\u00a0vivo","volume":"99","author":"Ehrhardt","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.omtn.2018.05.006_bib63","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1093\/nar\/gkv031","article-title":"Ad 2.0: a novel recombineering platform for high-throughput generation of tailored adenoviruses","volume":"43","author":"M\u00fcck-H\u00e4usl","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2018.05.006_bib64","series-title":"Molecular Cloning: A Laboratory Manual","author":"Sambrook","year":"2001"},{"key":"10.1016\/j.omtn.2018.05.006_bib65","first-page":"618","article-title":"The use of real-time quantitative polymerase chain reaction and comparative genomic hybridization to identify amplification of the REL gene in follicular lymphoma","volume":"111","author":"Goff","year":"2000","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.omtn.2018.05.006_bib66","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/978-1-4939-6700-1_6","article-title":"Analyses of HBV cccDNA Quantification and Modification","volume":"1540","author":"Xia","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.omtn.2018.05.006_bib67","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1038\/mt.2013.170","article-title":"Inactivation of hepatitis B virus replication in cultured cells and in\u00a0vivo with engineered transcription activator-like effector nucleases","volume":"21","author":"Bloom","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2018.05.006_bib68","doi-asserted-by":"crossref","DOI":"10.2144\/03353bm03","article-title":"Selection of optimal internal controls for gene expression profiling of liver disease","volume":"35","author":"Kim","year":"2003","journal-title":"Biotechniques"}],"container-title":["Molecular Therapy Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253118301033?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253118301033?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T08:34:07Z","timestamp":1788338047000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253118301033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":68,"alternative-id":["S2162253118301033"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2018.05.006","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"One-Vector System for Multiplexed CRISPR\/Cas9 against Hepatitis B Virus cccDNA Utilizing High-Capacity Adenoviral Vectors","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2018.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors.","name":"copyright","label":"Copyright"}]}}